title: Advancing the kinase field: new targets and second generation inhibitors.
authors.forename: Stefan
authors.initials: S
authors.lastname: Laufer
authors.forename: Jürgen
authors.initials: J
authors.lastname: Bajorath
mesh_terms: D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology; D015195:Drug Design; D055808:Drug Discovery / Q000379:methods / Q000639:trends; D004345:Drug Industry / Q000379:methods / Q000639:trends; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D015394:Molecular Structure; D058990:Molecular Targeted Therapy / Q000379:methods / Q000639:trends; D009369:Neoplasms / Q000188:drug therapy; D010770:Phosphotransferases / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism; D011485:Protein Binding; D047428:Protein Kinase Inhibitors / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D017434:Protein Structure, Tertiary; D020543:Proteome / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism; D054852:Small Molecule Libraries / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*
chemical_list: D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D047428:Protein Kinase Inhibitors; D020543:Proteome; D054852:Small Molecule Libraries; D010770:Phosphotransferases